These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 3184967)
1. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967 [TBL] [Abstract][Full Text] [Related]
2. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia. Chambers DJ; Takahashi A; Hearse DJ J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129 [TBL] [Abstract][Full Text] [Related]
3. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions. Galiñanes M; Murashita T; Hearse DJ J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125 [TBL] [Abstract][Full Text] [Related]
4. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. Kempsford RD; Hearse DJ J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart. Greenfield DT; Greenfield LJ; Hess ML J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928 [TBL] [Abstract][Full Text] [Related]
6. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution. Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296 [TBL] [Abstract][Full Text] [Related]
7. Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions. Choong YS; Gavin JB J Heart Lung Transplant; 1991; 10(4):537-46. PubMed ID: 1911796 [TBL] [Abstract][Full Text] [Related]
8. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution. Maruyama Y; Chambers DJ Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603 [TBL] [Abstract][Full Text] [Related]
9. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806 [TBL] [Abstract][Full Text] [Related]
10. Cardioplegia: relation of myocardial protection to infusion volume and duration. Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ Eur J Cardiothorac Surg; 1989; 3(2):130-3; discussion 134. PubMed ID: 2627463 [TBL] [Abstract][Full Text] [Related]
11. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia. Robinson LA; Harwood DL J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242 [TBL] [Abstract][Full Text] [Related]
12. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage. Galiñanes M; Chambers DJ; Hearse DJ J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551 [TBL] [Abstract][Full Text] [Related]
13. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat. Ledingham SJ; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223 [TBL] [Abstract][Full Text] [Related]
14. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate. Robinson LA; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150 [TBL] [Abstract][Full Text] [Related]
15. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution. Yang SS; Hearse DJ Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036 [TBL] [Abstract][Full Text] [Related]
16. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution. von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179 [TBL] [Abstract][Full Text] [Related]
17. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium. Baker JE; Boerboom LE; Olinger GN J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart]. Murashita T; Yasuda K Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717 [TBL] [Abstract][Full Text] [Related]
19. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart. Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170 [TBL] [Abstract][Full Text] [Related]
20. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. Qiu Y; Hearse DJ J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]